New Delhi, March 23 A study has identified a new biomarker for schizophrenia, which could also serve as a target for drugs to treat cognitive symptoms such as disorganized thinking or executive function.Schizophrenia is a mental health disorder characterized by an impaired ability to perceive...
biomarker
brain circuits
brain plasticity
cacna2d1
cerebrospinalfluid
clinical trials
cognitive symptoms
drug development
mental health disorders
neuroscience
peptide therapy
protein
research study
schizophrenia
synapses
New Delhi, February 13 A new study suggests that long COVID, which refers to 'SARS-CoV-2' symptoms that persist despite having recovered from the initial infection, and Alzheimer's disease may share underlying processes.Researchers, led by those from New York University in the US, found that...